Results of a single-arm pilot study of < sup > 32 < /sup > P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy

CONCLUSIONS: Endoscopic ultrasound-guided 32P microparticle implantation has an acceptable safety profile. This study also suggests clinically relevant benefits of combining 32P microparticles with standard-of-care systemic chemotherapy for patients with unresectable LAPC.PMID:34953400 | DOI:10.1016/j.esmoop.2021.100356

Source: Cancer Control - December 25, 2021 Category: Cancer & Oncology Authors: P J Ross H S Wasan D Croagh M Nikfarjam N Nguyen M Aghmesheh A M Nagrial D Bartholomeusz A Hendlisz T Ajithkumar C Iwuji N E Wilson D M Turner D C James E Young M T Harris Source Type: research